Ken Rosenthal of FOX Sports is reporting that free agent reliever Grant Balfour is considering filing a grievance over the Orioles’ recent decision to back out of a two-year, $15 million contract. Balfour contends he is as healthy as ever, and multiple doctors agree with him.
It is very hard to see what the Orioles are seeing, especially when no one else is seeing it. Remember that scene in Mallrats where the guy is staring at the painting looking for the hidden drawing, and everybody else walks by and sees it immediately? That’s the Orioles.
Balfour has pitched in at least 50 games per season dating back to 2008, his first full, healthy season after undergoing labrum and rotator cuff surgery in September 2005. He has compiled a 2.74 ERA in 380.1 relief innings with a 27 percent strikeout rate and nine percent walk rate. The O’s were getting an elite closer at a market rate — the Padres are paying Joaquin Benoit just about what the Orioles would have paid Balfour — so they must have seen something, real or not, that they didn’t like.
Balfour’s agent, Seth Levinson of ACES, responded to the situation in a press release. Via Dan Connolly of the Baltimore Sun:
“Grant is completely healthy and that was told to us today by Dr. Koco Eaton, a well-respected club physician (with the Tampa Bay Rays). Dr. Eaton’s opinion is based upon the fact that the MRI which was taken today is the same as the MRI which was taken in 2011 as a condition of the three-year contract that Grant signed with the A’s. Dr. Tim Kremchek (Cincinnati Reds), another well-respected club physician, reviewed the Orioles’ medical report and advised that he is remarkably impressed that there has been little change in Grant’s arm for almost 10 years. Now factor into the equation that Grant was a 2013 All-Star, pitched 65 games and another 3 scoreless innings in the postseason with a 94-95 mph fastball. The only reasonable conclusion is that Grant is healthy and the Orioles at the last moment changed their minds.”
Tim Brown of Yahoo! Sports reports that the Orioles have turned their attention to Fernando Rodney in the meantime.
It was reported Sunday that free agent right-hander Johnny Cueto had turned down a six-year, $120 million contract from the Diamondbacks. He’s hoping to land a bigger deal this winter and ESPN’s Jerry Crasnick has heard some chatter about what he’s looking for.
Jordan Zimmermann finalized a five-year, $110 million contract with the Tigers today, which works out to $22 million per season. Arizona’s offer to Cueto checked in at $20 million per season. A six-year offer to Cueto at the same AAV (average annual value) as Zimmermann would put him at $132 million, which is still a little shy of the figure stated by Crasnick. Of course, Cueto owns a 2.71 ERA (145 ERA+) over the last five seasons compared to a 3.14 ERA (123 ERA+) by Zimmermann during that same timespan, so there’s a case to be made that he should get more. Still, he’s the clear No. 3 starter on the market behind David Price and Zack Greinke.
CBS Sports’ Jon Heyman reports that the Dodgers, Giants, Red Sox, and Cubs are among the other teams who have interest in Cueto. One variable in his favor is that he is not attached to draft pick compensation, as he was traded from the Reds to the Royals during the 2015 season.
The rebuilding Braves have already been active on the trade market and they might not be done, as CBS Sports’ Jon Heyman reports that right-hander Shelby Miller has been a very popular name. In fact, around 20 teams have checked in.
Nothing is considered close and the Braves have set a very high asking price, mostly centered around offense. They asked for right-hander Luis Severino in talks with the Yankees and would expect outfielder Marcell Ozuna among other pieces from the Marlins. The Diamondbacks and Giants are among the other interested clubs.
Miller is under team control through 2018, so there’s not necessarily a sense of urgency to move him, but anything is possible with the way the Braves are doing things right now. The 25-year-old is coming off a year where he went 6-17, but that was about really rotten luck more than anything else, as he had a fine 3.02 ERA and 171/73 K/BB ratio over 205 1/3 innings. The Braves gave him the worst run support of any starter in the majors.
Jenrry Mejia appeared in just seven games this past season due to a pair of suspensions for performance-enhancing drugs, but Adam Rubin of ESPN New York reports that the Mets are expected to tender him a contract for 2016.
While the Mets were vocal about their disappointment in Mejia’s actions, it makes sense to keep him around as an option. Had he played a full season in 2015, he would have earned $2.595 million. He’s arbitration-eligible for the second time this winter and figures to receive a contract similar to his 2015 figure, but he’ll only be paid for the games he plays. He still has 100 games to serve on his second PED suspension, which means that he’ll only be paid for 62 games in 2016. This likely puts his salary closer to $1 million, which is a small price to pay for someone who could prove useful during the second half and beyond. He also won’t count toward the team’s 40-man roster until he’s active.
Mejia, who turned 26 in October, owns a 3.68 ERA in the majors and saved 28 games for the Mets in 2014. He’s currently pitching as a starter in the Dominican Winter League.
UPDATE: The deal is official. Bowman adds that Johnson will make $2.5 million in 2016.
6:11 p.m. ET: Jim Johnson enjoyed some success out of the Braves’ bullpen in 2015 until a midseason trade to the Dodgers and Mark Bowman of MLB.com reports that he has returned to Atlanta on a one-year contract. No word yet on the terms involved.
After an awful 2014 between the Athletics and Tigers, Johnson signed a one-year deal with the Braves last winter and bounced back to the tune of a 2.25 ERA and 33/14 K/BB ratio over 48 innings. He also saved nine games. However, things went south for him after a trade to the Dodgers in late July, as he put up an ugly 10.13 ERA in 23 appearances. He was left off the team’s roster for the NLDS against the Mets.
It’s unclear what role the Braves have in mind for Johnson, as Arodys Vizcaino finished the season as the closer, but they have made upgrading their bullpen a priority this winter.